Valuation Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-05-20 am EDT			5-day change	1st Jan Change
456.15 ^DKK	+3.98%		+4.00%	-26.92%

May. 20	Weight-loss company Noom pivots to smaller doses of compounded Wegovy	RE
May. 20	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	986,612	1,674,992	2,118,803	3,112,331	2,772,285	2,024,874	-	-
Change	-	69.77%	26.5%	46.89%	-10.93%	-26.96%	-	-
Enterprise Value (EV) ¹	984,211	1,684,152	2,121,013	3,109,107	2,848,764	2,088,234	2,045,564	2,015,107
Change	-	71.12%	25.94%	46.59%	-8.37%	-26.7%	-2.04%	-1.49%
P/E ratio	23.7x	35.4x	38.4x	37.5x	27.6x	17.4x	14.5x	12.9x
PBR	15.8x	24x	25.6x	29.4x	19.3x	10.1x	7.91x	6.42x
PEG	-	2.3x	2.2x	0.7x	1.3x	1.1x	0.7x	1.1x
Capitalization / Revenue	7.77x	11.9x	12x	13.4x	9.55x	6.05x	5.24x	4.73x
EV / Revenue	7.75x	12x	12x	13.4x	9.81x	6.24x	5.29x	4.71x
EV / EBITDA	16.4x	26x	25.8x	27.8x	19.3x	12.5x	10.3x	9.08x
EV / EBIT	18.2x	28.7x	28.4x	30.3x	22.2x	13.7x	11.4x	10.1x
EV / FCF	34.5x	57.4x	37x	45.5x	38.6x	31.9x	19.5x	15.5x
FCF Yield	2.9%	1.74%	2.7%	2.2%	2.59%	3.13%	5.13%	6.43%
Dividend per Share ²	4.55	5.2	6.2	9.4	11.4	13.24	15.57	17.34
Rate of return	2.13%	1.41%	1.32%	1.35%	1.83%	2.9%	3.41%	3.8%
EPS ²	9.005	10.37	12.22	18.62	22.63	26.2	31.51	35.26
Distribution rate	50.5%	50.1%	50.7%	50.5%	50.4%	50.5%	49.4%	49.2%
Net sales ¹	126,946	140,800	176,954	232,261	290,403	334,805	386,531	428,228
EBITDA ¹	59,879	64,669	82,171	111,987	147,446	166,543	198,072	222,020
EBIT ¹	54,126	58,644	74,809	102,574	128,339	151,969	179,340	199,255
Net income ¹	42,138	47,757	55,525	83,683	100,988	116,909	139,976	155,842
Net Debt ¹	-2,401	9,160	2,210	-3,224	76,479	63,360	20,690	-9,767
Reference price ²	213.32	367.50	469.00	698.10	624.20	456.15	456.15	456.15
Nbr of stocks (in thousands)	4,624,923	4,557,801	4,517,704	4,458,288	4,441,340	4,439,053	-	-
Announcement Date	2/3/21	2/2/22	2/1/23	1/31/24	2/5/25	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio (N)	EV / Sales (N)	EV / EBITDA (N)	Yield (N)	Capi.($)
NOVO NORDISK A/S	16.75x	6.01x	12.07x	3.02%	294B
ELI LILLY AND COMPANY	35.63x	11.79x	26.83x	0.78%	678B
JOHNSON & JOHNSON	14.61x	4.07x	11.2x	3.43%	367B
ABBVIE INC.	28.17x	6.39x	13.27x	3.52%	328B
ROCHE HOLDING AG	14.23x	3.48x	8.64x	3.8%	251B
NOVARTIS AG	15.98x	4.27x	10.33x	3.55%	215B
ASTRAZENECA PLC	21.94x	4.06x	11.75x	2.32%	215B
MERCK & CO., INC.	9.77x	3.21x	6.92x	4.18%	194B
AMGEN INC.	20.6x	5.48x	10.69x	3.48%	148B
GILEAD SCIENCES, INC.	17.51x	5x	9.15x	3.05%	132B
Average	19.52x	5.38x	12.09x	3.11%	282.2B
Weighted average by Cap.	22.20x	6.42x	14.62x	2.75%